Results 111 to 120 of about 18,980 (173)

Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancer. [PDF]

open access: yesCell Rep Med
Cottu P   +19 more
europepmc   +1 more source

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC. [PDF]

open access: yesESMO Open
Girard N   +24 more
europepmc   +1 more source

Pre-synthetic redox control of structure and properties in copper TTFtt coordination polymers. [PDF]

open access: yesChem Sci
Jiang N   +12 more
europepmc   +1 more source

A founder BRCA1 exonic duplication involving breakpoint in T2T reference genome-specific region results in constitutional fusion transcript. [PDF]

open access: yesNPJ Genom Med
Schwartz M   +22 more
europepmc   +1 more source

Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma. [PDF]

open access: yesESMO Open
Shitara K   +19 more
europepmc   +1 more source

Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial.

open access: yesJAMA Netw Open
Leachman SA   +10 more
europepmc   +1 more source

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial. [PDF]

open access: yesESMO Open
Curigliano G   +23 more
europepmc   +1 more source

Combining Population Genomics With Ancient DNA to Understand Island Colonisation History of the Madagascar Turtle Dove. [PDF]

open access: yesMol Ecol
Dwivedi N   +15 more
europepmc   +1 more source

Peritonitis and paralytic ileus due to COVID-19 in a 29 weeks pregnant woman: a case report. [PDF]

open access: yesBMC Pregnancy Childbirth
Mahiou K   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy